News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The systemic therapy options available for mCRPC – National Comprehensive Cancer Network
Hiba Ahmad/doximity.com
Apr 22, 2025, 13:59

The systemic therapy options available for mCRPC – National Comprehensive Cancer Network

National Comprehensive Cancer Network (NCCN) shared a post on LinkedIn:

“Join us on April 28 for the Optimizing Patient Outcomes webinar on Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates.

Hiba Ahmad from the University of Colorado Cancer Center will summarize the systemic therapy options available for metastatic castration-resistant prostate cancer (mCRPC) and more.

Register now.”

The systemic therapy options available for mCRPC - National Comprehensive Cancer Network

cancer fight against cancer Global fight against cancer mCRPC metastatic castration-resistant prostate cancer National Comprehensive Cancer Network NCCN OncoDaily Oncology University of Colorado Cancer Center
Special Coverage
Insight
Aug 25, 2025, 14:34
Philipp Ivanyi Highlights Need for Reconsideration in Cancer Treatment Landscape
Voices
Aug 25, 2025, 14:32
Douglas Flora: America Is Abandoning One of the Greatest Medical Breakthroughs
Insight
Aug 25, 2025, 14:21
Anirban Maitra Highlights New Paper on Therapeutic Targets for Pancreatic Cancer
OncoDaily Pulse
Aug 25, 2025, 14:16
Padraic O’Malley: Meet the Experts of VIRO 2025
Insight
Aug 25, 2025, 14:15
Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld
Voices
Aug 25, 2025, 13:49
Mario I Fernandez: Joining LATAM Bladder Cancer Experts at the IBCG in Houston
Voices
Aug 25, 2025, 13:34
Gevorg Tamamyan: Hemostasis Today - A New Era in Hemostasis and Thrombosis Reporting
Career Updates
Aug 25, 2025, 13:16
Jouliana Sadek Joins the Kyowa Kirin North America Team as Associate Director, Medical Value Outcomes Liaison
FDA Approvals
Aug 25, 2025, 13:00
FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC
Science
Aug 25, 2025, 12:37
Stephen V Liu: Chronic Kidney Disease Risk After Cisplatin Chemotherapy
Insight
Aug 25, 2025, 12:23
Catharine Young: Why We Fund Science and Specifically mRNA Research
Voices
Aug 25, 2025, 12:17
Amalya Sargsyan: Some People Don’t Just Save Lives, They Change the Way Others Do It